National
Fla. Log Cabin members tilt toward Romney
Former Massachusetts governor wins straw poll at ‘gay’ GOP caucus in Miami
MIAMI — Two days before the hotly contested GOP presidential primary in Florida, former Massachusetts Gov. Mitt Romney beat his three remaining rivals by a lopsided margin Saturday night in a straw poll of gay Republican activists in the Sunshine State.
The poll of just 34 Log Cabin officers and active members from the Miami, Fort Lauderdale, and Tampa areas was billed as an unscientific sample of LGBT Republicans in the state.
It took place at an informal “cocktail caucus” of Log Cabin members at a Miami restaurant. In secret balloting, Romney received 24 votes, former U.S. House Speaker Newt Gingrich received 6 votes, Texas Congressman Ron Paul received 4 votes, and former U.S. Sen. Rick Santorum of Pennsylvania received no votes.
“It’s a reflection of some of our most active and politically informed members mostly from the Miami-Dade area,” said R. Clarke Cooper, president of the national Log Cabin Republicans organization.
Officials from the group’s Florida chapters said the outcome was consistent with anecdotal information they’ve received from club members and gay and lesbian Republicans across the state – that a majority of Florida’s LGBT Republicans, including those who initially backed former Utah Gov. Jon Huntsman and Texas Congressman Ron Paul, have shifted their support to Romney.
Huntsman has dropped out of the race and most political observers believe Paul has little chance of capturing the Republican nomination for president.
Shortly after Log Cabin’s cocktail caucus adjourned on Saturday evening, the Miami Herald, El Nuevo Herald, and the Tampa Bay Times released the findings of a joint poll that showed a large majority of the state’s Republican voters were in agreement with the Log Cabin members.
The poll of 800 likely GOP voters showed Romney had a commanding lead of 42 percent, with Gingrich coming in second with 31 percent. Santorum came in third with 14 percent. Paul received 6 percent support from the GOP voter sample.
The Florida primary takes place on Tuesday. Thousands of GOP voters have already cast their bollots under the state’s early voting law.
Mimi Planas, co-director of Log Cabin Republicans of Miami, said her group organized the cocktail caucus in honor of members of the national Log Cabin Republicans board of directors, which met in Miami earlier in the day.
Planas, a Cuban American, was among several Hispanic Log Cabin members and officers that attended the caucus. The other co-director of the Miami chapter, Eddie Sierra, is also Cuban American.
Planas said her perception was that many LGBT Hispanic Republicans were in agreement with a majority of their straight counterparts in believing that Romney would be the best candidate to challenge President Obama in the general election in November.
“I can you tell that I, as a Republican gay voter, will be voting for Romney in the Republican primary and will support his campaign 100 percent,” said Planas, who works as an executive assistant to the president of a Miami company.
She acknowledges that Romney isn’t as supportive on LGBT issues as she would like, especially on the issue of same-sex marriage, which Romney opposes. But Planas and nearly all the others at the cocktail gathering who spoke with the Blade said their decision on which candidate to support for president was based on a wide range of issues in addition to LGBT issues.
“We see many of the LGBT Democrats as being one-issue voters,” said Planas. “We’re multi-issue voters who care a lot about a strong national defense, regulatory reform, and less, not more, government intrusion in the private sector.”
Jim Pease, president of the Tampa Bay Log Cabin Republicans chapter, said he’s developed a “sound bite” answer over the past ten years to the question by gay Democrats and others on why gay Republicans support a party or candidates that oppose LGBT rights.
“If you’re going to be a single-issue voter, than, yes, you’re going to have a problem,” he said. “But you’ve got to look at the whole picture. I’ve never found any candidate whose platform I agree with 100 percent.”
Pease added, “I have to look at what’s best for America. I want to keep America safe, I want a strong defense. I want a strong economy. I want to keep it so we have the liberties and the freedoms that we enjoy so we can be gay Republicans, so that we can be gay Democrats.”
Andy Eddy, president of the Log Cabin Chapter of Broward County, which includes the city of Fort Lauderdale, said he, too, is supporting Romney.
“I was originally supporting Huntsman and I was leaning toward Gingrich,” Eddy said. “But I was disappointed in a couple of things about Gingrich. I decided Romney would be the best person to win the Republican ticket in November 2012.”
Romney, Gingrich, and Santorum have each signed a pledge vowing to support a U.S. constitutional amendment to ban same-sex marriage. The anti-gay National Organization for Marriage sent the pledge to all Republican presidential candidates last year. Paul and Huntsman were the only two of the original ‘top tier’ candidates to decline to sign the pledge.
Cooper, who heads the national Log Cabin organization, and several officials with the group’s Florida chapters, including Eddy, said on Saturday that it would be unlikely that the national group would decline to support Romney in November should he win the nomination based on his position on gay marriage.
Cooper said Log Cabin traditionally waits to decide whether to endorse a Republican presidential candidate until the time of the GOP national convention.
In a controversial decision, the national Log Cabin Republicans group chose not to endorse President George W. Bush for re-election in 2004 based on Bush’s support for the Federal Marriage Amendment, which would add a permanent ban on same-sex marriage in the U.S. Constitution.
Eddy noted that Log Cabin’s action in 2004 left it open for its chapters throughout the country to endorse Bush, enabling the chapters to avoid sanctions or expulsion from their local or state Republican committees. A number of Log Cabin chapters, including those in Miami-Dade and Broward County in Florida, have been accepted as official arms of the Republican Party Committees in their respective counties or cities.
Cooper said he and other Log Cabin officials believe Romney’s position on gay marriage is more nuanced than that of President Bush in 2004, who actively backed a constitutional ban. Cooper said that Romney, while signing the National Organization for Marriage pledge, refused to sign a “far more extreme” pledge against gay marriage sent to him and other candidates by the Iowa based Christian conservative group The Family Leader.
According to Cooper, Log Cabin’s decision not to endorse Bush in 2004 under group’s then president Patrick Guerriero was also based, in part, on the national Republican Party’s strong backing of referendums in several states seeking to ban gay marriage.
Cooper said the party was using gay marriage as a “wedge issue” to divide the electorate and increase the turnout of conservative voters at the polls.
“Romney has said doing a constitutional amendment is not realistic and that’s not something that’s going to happen,” Cooper said. “So when you have candidates like him and Ron Paul saying that’s not a realistic option, that’s far different than from saying I’m going to push for a federal marriage amendment.”
Eddy said he and other Log Cabin members planned to attend a Romney rally Sunday afternoon in Pompano Beach near Fort Lauderdale.
Jerame Davis, executive director of National Stonewall Democrats, an LGBT group aligned with the Democratic Party, disputes Cooper’s view that Romney’s statement that a federal constitutional amendment seeking to ban gay marriage is not likely to be seriously considered offsets Romney’s support for NOM’s federal marriage amendment pledge.
“It’s the height of hypocrisy that Log Cabin would try to excuse Mitt Romney’s adoption of NOM’s insidious hate pledge,” Davis said. “In 2004, LCR took a principled stand and refused to endorse George W. Bush for his misguided push for a federal marriage amendment.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
